| S1031 |
3-Hydroxybutyric acid (BHB acid)
|
3-Hydroxybutyric acid (BHB) is a small molecule metabolite that is elevated in type I diabetes.,
|
-
BMC Medicine, April 15, 2022, 148
-
BMC Medicine, April 15 2022, 148
-
BMC Medicine, 2022, 148
|
|
| S1466 |
Calcitriol (1,25-Dihydroxyvitamin D3)
|
Calcitriol is a nonselective vitamin D receptor activator/agonist(VDRA), exhibiting a 10-fold higher vitamin D receptor (VDR) binding affinity(IC50=0.4 nM) than the selective VDRA paricalcitol. Solutions are unstable and should be fresh-prepared.
|
-
Anticancer Research, June 2021, 2945-2952
-
bioRxiv, February 08, 2024, nan
-
Cells, August 20, 2021, 2149
|
|
| S2298 |
Fisetin
|
Fisetin (Fustel) is a potent sirtuin activating compound (STAC) and an agent that modulates sirtuins.
|
-
Sci Adv, 2025, 11(17):eads1875
-
Mol Cancer, 2024, 23(1):222
-
Cell Death Dis, 2024, 15(8):608
|
|
| S4606 |
GSH (L-Glutathione reduced)
|
GSH (Glutathione) acts as an antioxidant, a free radical scavenger and a detoxifying agent. It is a tripeptide comprised of three amino acids (cysteine, glutamic acid, and glycine) present in most mammalian tissue.
|
-
Redox Biol, 2025, 83:103615
-
Cell Death Dis, 2025, 16(1):396
-
Elife, 2025, 13RP100406
|
|
| S1236 |
Leucovorin Calcium Pentahydrate (Folinic acid)
|
Leucovorin (Folinic acid) Calcium Pentahydrate is a derivative of folic acid, which can be used to increase levels of folic acid under conditions favoring folic acid inhibition.Solutions are unstable and should be fresh-prepared.
|
-
Journal of Hepatocellular Carcinoma, March 27, 2023, 483-495
-
Journal of Student Research, August 2024, nan
-
J Exp Clin Cancer Res, 2025, 44(1):13
|
|
| S5726 |
Liothyronine (Triiodothyronine, T3)
|
T3 (Triiodothyronine) is a thyroid hormone that affects various physiological process in the body, including growth and development, metabolism, body temperature, and heart rate.This product is soluble but easy to precipitate after freezing in DMSO. 0.1 M NaOH is recommended as a stock solution.
|
-
STAR Protocols, 2025, 103834
-
STAR Protoc, 2025, 6(2):103834
-
Cancers (Basel), 2024, 16(23)4069
|
|
| S5324 |
6-OHDA (Oxidopamine hydrobromide)
|
6-OHDA (Oxidopamine hydrobromide) is a neurotoxic synthetic organic compound that acts as an antagonist of the neurotransmitter dopamine with potential antineoplastic activity. 6-OHDA (Oxidopamine hydrobromide) can be used to induce animal models of Parkinson's Disease.Solutions are unstable and should be fresh-prepared.
|
-
Stem Cells Translational Medicine, June 26, 2017, 1803-1814
-
bioRxiv, December 17, 2024, nan
-
Cancer Discovery, 2025, 202-226
|
|